Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Clin Exp Pathol ; 8(7): 8536-44, 2015.
Article in English | MEDLINE | ID: mdl-26339430

ABSTRACT

UNLABELLED: Plasma cell neoplasm (PCM) is a medullary and extra medullary proliferation of clonal plasma cells that occurs due to accidental translocation of proto-oncogenes into immunoglobulin (Ig) gene loci. While the majority of plasma cell neoplasms are monoclonal, up to 2% of the PCMs [1] considered being biclonal based on electrophoretic analysis, characterized by secretion of paraprotein with two distinct heavy chains or light chains are possible and present unique diagnostic challenges. METHODS: Traditionally protein electrophoresis has been used to diagnose, characterize, and monitor progression of plasma cell neoplasm. To characterize neoplastic plasma cells, in our institution, other ancillary studies, including in situ hybridization, flow cytometric analyses of plasma cell surface markers and cytoplasmic immunoglobulins with DNA ploidy, are also utilized routinely. RESULTS: We present two cases of plasma cell myeloma in which the neoplastic plasma cells shows production of cytoplasmic kappa and lambda light chain, with secretion of free lambda light chain only. Co-expression of kappa and lambda light chain by the same neoplastic plasma cells is a rare but reported phenomenon. CONCLUSIONS: Our study indicates that serum electrophoresis alone could mischaracterize biphenotypic myeloma as monotypic plasma cell myelomas in the absence of additional testing methods.


Subject(s)
Biomarkers, Tumor/analysis , Immunoglobulin kappa-Chains/analysis , Immunoglobulin lambda-Chains/analysis , Multiple Myeloma/immunology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/blood , Biomarkers, Tumor/genetics , Electrophoresis, Capillary , Fatal Outcome , Female , Flow Cytometry , Humans , Immunoglobulin kappa-Chains/blood , Immunoglobulin kappa-Chains/genetics , Immunoglobulin lambda-Chains/blood , Immunoglobulin lambda-Chains/genetics , Immunohistochemistry , Immunophenotyping/methods , In Situ Hybridization , Male , Middle Aged , Multiple Myeloma/blood , Multiple Myeloma/diagnosis , Multiple Myeloma/drug therapy , Multiple Myeloma/genetics , Phenotype , Predictive Value of Tests , RNA, Messenger/genetics , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...